COVID-19 and obesity: fighting two pandemics with intermittent fasting
References
- 1. Gao MAssociations between body-mass index and COVID-19 severity in 6.9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021;9:350–359.[Google Scholar]
- 2. Kang ZObesity is a potential risk factor contributing to clinical manifestations of COVID-19. Int. J. Obes. (Lond.) 2020;44:2479–2485.[Google Scholar]
- 3. Simonnet AHigh prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring) 2020;28:1195–1199.[Google Scholar]
- 4. O’Hearn MCoronavirus disease 2019 hospitalizations attributable to cardiometabolic conditions in the United States: a comparative risk assessment analysis. J. Am. Heart Assoc. 2021;10[PubMed][Google Scholar]
- 5. Hendren N.SAssociation of body mass index and age with morbidity and mortality in patients hospitalized with COVID-19: results from the American Heart Association COVID-19 Cardiovascular Disease Registry. Circulation. 2021;143:135–144.[PubMed][Google Scholar]
- 6. Guerson-Gil ASex-specific impact of severe obesity in the outcomes of hospitalized patients with COVID-19: a large retrospective study from the Bronx, New York. Eur. J. Clin. Microbiol. Infect. Dis. 2021 doi: 10.1007/s10096-021-04260-z. Published online May 6, 2021. ] [[Google Scholar]
- 7. Alarcon P.CAdipocyte inflammation and pathogenesis of viral pneumonias: an overlooked contribution. Mucosal Immunol. 2021 doi: 10.1038/s41385-021-00404-8. Published online May 6, 2021. ] [[Google Scholar]
- 8. Codo A.CElevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis. Cell Metab. 2020;32:437–446.e435.[Google Scholar]
- 9. Aschwanden CFive reasons why COVID herd immunity is probably impossible. Nature. 2021;591:520–522.[PubMed][Google Scholar]
- 10. Neidich S.DIncreased risk of influenza among vaccinated adults who are obese. Int. J. Obes. (Lond.) 2017;41:1324–1330.[Google Scholar]
- 11. Paich H.AOverweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus. Obesity (Silver Spring) 2013;21:2377–2386.[Google Scholar]
- 12. Del Valle D.MAn inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 2020;26:1636–1643.[Google Scholar]
- 13. Laguna-Goya RIL-6-based mortality risk model for hospitalized patients with COVID-19. J. Allergy Clin. Immunol. 2020;146:799–807.e799.[Google Scholar]
- 14. Cariou BPhenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020;63:1500–1515.[Google Scholar]
- 15. Guo WDiabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab. Res. Rev. 2020;36[Google Scholar]
- 16. Yan YClinical characteristics and outcomes of patients with severe Covid-19 with diabetes. BMJ Open Diabetes Res. Care. 2020;8[Google Scholar]
- 17. Bode BGlycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J. Diabetes Sci. Technol. 2020;14:813–821.[Google Scholar]
- 18. Zhu LAssociation of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31:1068–1077.e1063.[Google Scholar]
- 19. Smith S.MImpaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19. J. Med. Virol. 2021;93:409–415.[Google Scholar]
- 20. Carrasco-Sanchez F.JAdmission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry. Ann. Med. 2021;53:103–116.[Google Scholar]
- 21. Iacobellis GAdmission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes. Diabetes Res. Clin. Pract. 2020;164[Google Scholar]
- 22. Wang SFasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study. Diabetologia. 2020;63:2102–2111.[Google Scholar]
- 23. Wang Q. O-GlcNAc transferase promotes influenza A virus-induced cytokine storm by targeting interferon regulatory factor-5. Sci. Adv. 2020;6
- 24. Wang XExpression levels of interferon regulatory factor 5 (IRF5) and related inflammatory cytokines associated with severity, prognosis, and causative pathogen in patients with community-acquired pneumonia. Med. Sci. Monit. 2018;24:3620–3630.[Google Scholar]
- 25. Sindhu SEnhanced adipose expression of interferon regulatory factor (IRF)-5 associates with the signatures of metabolic inflammation in diabetic obese patients. Cells. 2020;9:730.[Google Scholar]
- 26. Dalmas EIrf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity. Nat. Med. 2015;21:610–618.[PubMed][Google Scholar]
- 27. Stoy NInvolvement of interleukin-1 receptor-associated kinase 4 and interferon regulatory factor 5 in the immunopathogenesis of SARS-CoV-2 infection: implications for the treatment of COVID-19. Front. Immunol. 2021;12[Google Scholar]
- 28. Walls A.CStructure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181:281–292.e286.[Google Scholar]
- 29. Mehdipour A.R., Hummer GDual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike. Proc. Natl Acad. Sci. U. S. A. 2021;118[Google Scholar]
- 30. Brufsky AHyperglycemia, hydroxychloroquine, and the COVID-19 pandemic. J. Med. Virol. 2020;92:770–775.[Google Scholar]
- 31. Porsche C.EObesity results in adipose tissue T cell exhaustion. JCI Insight. 2021;6[Google Scholar]
- 32. Chen GClinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 2020;130:2620–2629.[Google Scholar]
- 33. Mohamed-Ali VSubcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 1997;82:4196–4200.[PubMed][Google Scholar]
- 34. Alti DEmergence of leptin in infection and immunity: scope and challenges in vaccines formulation. Front. Cell. Infect. Microbiol. 2018;8:147.[Google Scholar]
- 35. Zhang A.JLeptin mediates the pathogenesis of severe 2009 pandemic influenza A(H1N1) infection associated with cytokine dysregulation in mice with diet-induced obesity. J. Infect. Dis. 2013;207:1270–1280.[PubMed][Google Scholar]
- 36. van der Voort P.H.JLeptin levels in SARS-CoV-2 infection related respiratory failure: a cross-sectional study and a pathophysiological framework on the role of fat tissue. Heliyon. 2020;6[Google Scholar]
- 37. Wang JLeptin correlates with monocytes activation and severe condition in COVID-19 patients. J. Leukoc. Biol. 2021 doi: 10.1002/JLB.5HI1020-704R. Published online January 6, 2021. [] [[PubMed][Google Scholar]
- 38. Honce RObesity-related microenvironment promotes emergence of virulent influenza virus strains. mBio. 2020;11[Google Scholar]
- 39. Karlsson E.ADiet-induced obesity in mice reduces the maintenance of influenza-specific CD8 memory T cells. J. Nutr. 2010;140:1691–1697.[Google Scholar]
- 40. Rebeles JObesity-induced changes in T-cell metabolism are associated with impaired memory T-cell response to influenza and are not reversed with weight loss. J. Infect. Dis. 2019;219:1652–1661.[Google Scholar]
- 41. Frasca DObesity decreases B cell responses in young and elderly individuals. Obesity (Silver Spring) 2016;24:615–625.[Google Scholar]
- 42. Polack F.PSafety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N. Engl. J. Med. 2020;383:2603–2615.[Google Scholar]
- 43. Baden L.REfficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 2021;384:403–416.[Google Scholar]
- 44. Pellini RObesity may hamper SARS-CoV-2-specific vaccine. medRxiv. 2021 doi: 10.1101/2021.02.24.21251664. Published online February 26, 2021. [[PubMed][Google Scholar]
- 45. Frasca DInfluence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients. PLoS One. 2021;16[Google Scholar]
- 46. Mao RManifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 2020;5:667–678.[Google Scholar]
- 47. Wang WDetection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323:1843–1844.[Google Scholar]
- 48. Li M.YExpression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect. Dis. Poverty. 2020;9:45.[Google Scholar]
- 49. Kruglikov I.LObesity and diabetes as comorbidities for COVID-19: underlying mechanisms and the role of viral-bacterial interactions. Elife. 2020;9[Google Scholar]
- 50. Gu SAlterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza. Clin. Infect. Dis. 2020;71:2669–2678.[Google Scholar]
- 51. Yeoh Y.KGut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:608–706.[Google Scholar]
- 52. Belkaid Y., Harrison O.JHomeostatic immunity and the microbiota. Immunity. 2017;46:562–576.[Google Scholar]
- 53. Dickson R.PThe microbiome and critical illness. Lancet Respir. Med. 2016;4:59–72.[Google Scholar]
- 54. Zuo TAlterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159:944–955.e948.[Google Scholar]
- 55. Mohammad S., Thiemermann CRole of metabolic endotoxemia in systemic inflammation and potential interventions. Front. Immunol. 2020;11[Google Scholar]
- 56. Lee J.HIntermittent fasting: physiological implications on outcomes in mice and men. Physiology (Bethesda) 2020;35:185–195.[PubMed][Google Scholar]
- 57. Gill S., Panda SA smartphone app reveals erratic diurnal eating patterns in humans that can be modulated for health benefits. Cell Metab. 2015;22:789–798.[Google Scholar]
- 58. Wilkinson M.JTen-hour time-restricted eating reduces weight, blood pressure, and atherogenic lipids in patients with metabolic syndrome. Cell Metab. 2020;31:92–104.e105.[Google Scholar]
- 59. Gabel KEffects of 8-hour time restricted feeding on body weight and metabolic disease risk factors in obese adults: a pilot study. Nutr. Healthy Aging. 2018;4:345–353.[Google Scholar]
- 60. Kesztyus DAdherence to time-restricted feeding and impact on abdominal obesity in primary care patients: results of a pilot study in a pre-post design. Nutrients. 2019;11:2854.[Google Scholar]
- 61. Cienfuegos SEffects of 4- and 6-h time-restricted feeding on weight and cardiometabolic health: a randomized controlled trial in adults with obesity. Cell Metab. 2020;32:366–378.e363.[PubMed][Google Scholar]
- 62. Jamshed HEarly time-restricted feeding improves 24-hour glucose levels and affects markers of the circadian clock, aging, and autophagy in humans. Nutrients. 2019;11:1234.[Google Scholar]
- 63. Sutton E.FEarly time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes. Cell Metab. 2018;27:1212–1221.e1213.[Google Scholar]
- 64. Kim Y.HThermogenesis-independent metabolic benefits conferred by isocaloric intermittent fasting in ob/ob mice. Sci. Rep. 2019;9:2479.[Google Scholar]
- 65. Kim K.HIntermittent fasting promotes adipose thermogenesis and metabolic homeostasis via VEGF-mediated alternative activation of macrophage. Cell Res. 2017;27:1309–1326.[Google Scholar]
- 66. Chaix ATime-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges. Cell Metab. 2014;20:991–1005.[Google Scholar]
- 67. Solerte S.BSitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, case-control, retrospective, observational study. Diabetes Care. 2020;43:2999–3006.[Google Scholar]
- 68. Mirani MImpact of comorbidities and glycemia at admission and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes with COVID-19: a case series from an academic hospital in Lombardy, Italy. Diabetes Care. 2020;43:3042–3049.[PubMed][Google Scholar]
- 69. Deacon C.FPhysiology and pharmacology of DPP-4 in glucose homeostasis and the treatment of type 2 diabetes. Front. Endocrinol. (Lausanne) 2019;10:80.[Google Scholar]
- 70. Dogan SThe influence of different calorie restriction protocols on serum pro-inflammatory cytokines, adipokines and IGF-I levels in female C57BL6 mice: short term and long term diet effects. Meta Gene. 2017;12:22–32.[Google Scholar]
- 71. Faris M.AIntermittent fasting during Ramadan attenuates proinflammatory cytokines and immune cells in healthy subjects. Nutr. Res. 2012;32:947–955.[PubMed][Google Scholar]
- 72. Almeneessier A.SThe effects of diurnal intermittent fasting on proinflammatory cytokine levels while controlling for sleep/wake pattern, meal composition and energy expenditure. PLoS One. 2019;14[Google Scholar]
- 73. Cignarella FIntermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota. Cell Metab. 2018;27:1222–1235.e1226.[Google Scholar]
- 74. Longo V.D., Mattson M.PFasting: molecular mechanisms and clinical applications. Cell Metab. 2014;19:181–192.[Google Scholar]
- 75. Jordan SDietary intake regulates the circulating inflammatory monocyte pool. Cell. 2019;178:1102–1114.e1117.[Google Scholar]
- 76. Collins NThe bone marrow protects and optimizes immunological memory during dietary restriction. Cell. 2019;178:1088–1101.e1015.[Google Scholar]
- 77. Cheng C.WProlonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell Stem Cell. 2014;14:810–823.[Google Scholar]
- 78. Hannan M.AIntermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: crosstalk among calorie restriction, autophagy and immune response. Immunol. Lett. 2020;226:38–45.[Google Scholar]
- 79. Namkoong SAutophagy dysregulation and obesity-associated pathologies. Mol. Cells. 2018;41:3–10.[Google Scholar]
- 80. Wei SIntermittent administration of a fasting-mimicking diet intervenes in diabetes progression, restores beta cells and reconstructs gut microbiota in mice. Nutr. Metab. (Lond.) 2018;15:80.[Google Scholar]
- 81. Li GIntermittent fasting promotes white adipose browning and decreases obesity by shaping the gut microbiota. Cell Metab. 2017;26:672–685.e674.[Google Scholar]
- 82. Pietrabissa G., Simpson S.GPsychological consequences of social isolation during COVID-19 outbreak. Front. Psychol. 2020;11:2201.[Google Scholar]
- 83. Stockwell SChanges in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lockdown: a systematic review. BMJ Open Sport Exerc. Med. 2021;7[Google Scholar]
- 84. Di Renzo LEating habits and lifestyle changes during COVID-19 lockdown: an Italian survey. J. Transl. Med. 2020;18:229.[Google Scholar]
- 85. Giacalone DReported changes in dietary habits during the COVID-19 lockdown in the Danish population: the Danish COVIDiet Study. Front. Nutr. 2020;7[Google Scholar]
- 86. Rolland BGlobal changes and factors of increase in caloric/salty food intake, screen use, and substance use during the early COVID-19 containment phase in the general population in France: survey study. JMIR Public Health Surveill. 2020;6:19630.[Google Scholar]
- 87. Ruiz-Roso M.BCOVID-19 lockdown and changes of the dietary pattern and physical activity habits in a cohort of patients with type 2 diabetes mellitus. Nutrients. 2020;12:2327.[Google Scholar]
- 88. Hussin N.MEfficacy of fasting and calorie restriction (FCR) on mood and depression among ageing men. J. Nutr. Health Aging. 2013;17:674–680.[PubMed][Google Scholar]
- 89. Igwe OA review of effects of calorie restriction and fasting with potential relevance to depression. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2020 doi: 10.1016/j.pnpbp.2020.110206. Published online December 11, 2020. [] [[PubMed][Google Scholar]
- 90. Lowe D.AEffects of time-restricted eating on weight loss and other metabolic parameters in women and men with overweight and obesity: the TREAT randomized clinical trial. JAMA Intern. Med. 2020;180:1491–1499.[Google Scholar]
- 91. Duriancik D.MAge, calorie restriction, and age of calorie restriction onset reduce maturation of natural killer cells in C57Bl/6 mice. Nutr. Res. 2018;55:81–93.[Google Scholar]
- 92. Anton S.DThe effects of time restricted feeding on overweight, older adults: a pilot study. Nutrients. 2019;11:1500.[Google Scholar]
- 93. Garcia L.FImmune response, inflammation, and the clinical spectrum of COVID-19. Front. Immunol. 2020;11:1441.[Google Scholar]
- 94. Suthar M.SRapid generation of neutralizing antibody responses in COVID-19 patients. Cell Rep. Med. 2020;1[Google Scholar]
- 95. Tang YCytokine storm in COVID-19: the current evidence and treatment strategies. Front. Immunol. 2020;11:1708.[Google Scholar]
- 96. Wu Z., McGoogan J.MCharacteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–1242.[PubMed][Google Scholar]
- 97. Zhang DFrontline science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes. J. Leukoc. Biol. 2021;109:13–22.[Google Scholar]
- 98. Golbidi SHealth benefits of fasting and caloric restriction. Curr. Diab. Rep. 2017;17:123.[PubMed][Google Scholar]
- 99. Bellicha AEffect of exercise training on weight loss, body composition changes, and weight maintenance in adults with overweight or obesity: an overview of 12 systematic reviews and 149 studies. Obes. Rev. 2021 doi: 10.1111/obr.13256. Published online May 6, 2021. [] [[PubMed][Google Scholar]
- 100. Bhutani SAlternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans. Obesity (Silver Spring) 2013;21:1370–1379.[PubMed][Google Scholar]
- 101. Ashtary-Larky DEffects of intermittent fasting combined with resistance training on body composition: a systematic review and meta-analysis. Physiol. Behav. 2021;237[PubMed][Google Scholar]
- 102. Sallis RPhysical inactivity is associated with a higher risk for severe COVID-19 outcomes: a study in 48 440 adult patients. Br. J. Sports Med. 2021 doi: 10.1136/bjsports-2021-104080. Published online April 13, 2021. ] [[Google Scholar]
- 103. Herazo-Beltran YPredictors of perceived barriers to physical activity in the general adult population: a cross-sectional study. Braz. J. Phys. Ther. 2017;21:44–50.[Google Scholar]
- 104. Verdecchia PThe pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur. J. Intern. Med. 2020;76:14–20.[Google Scholar]
- 105. Lukassen SSARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. EMBO J. 2020;39[Google Scholar]
- 106. Donoghue MA novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 2000;87:E1–E9.[PubMed][Google Scholar]
- 107. Kruglikov I.L., Scherer P.EThe role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections. Obesity (Silver Spring) 2020;28:1187–1190.[Google Scholar]
- 108. Al Heialy SRegulation of angiotensin- converting enzyme 2 in obesity: implications for COVID-19. Front. Physiol. 2020;11[Google Scholar]
- 109. Datta P.KSARS-CoV-2 pandemic and research gaps: understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy. Theranostics. 2020;10:7448–7464.[Google Scholar]
- 110. Camelo LIntermittent fasting exerts beneficial metabolic effects on blood pressure and cardiac structure by modulating local renin-angiotensin system in the heart of mice fed high-fat or high-fructose diets. Nutr. Res. 2019;63:51–62.[PubMed][Google Scholar]